← Back to ROIV

Roivant Sciences Ltd. financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Dec 2025Filed 06/02/2026Sep 2025Filed 10/11/2025Jun 2025Filed 06/08/2026Dec 2024Filed 06/02/2026Sep 2024Filed 10/11/2025Jun 2024Filed 11/08/2025Dec 2023Filed 10/02/2025
$1.4$2$1.6$2.2$9$4.5$8$16
−$190−$266−$114−$223$169−$230$95$5,096
−$0.26−$0.38−$0.17−$0.33$0.23−$0.31$0.12$6.03
721697681680723735782844

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.